The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group Poster Session (P722-P740) - Top-Institutions - MDSpire

The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group Poster Session (P722-P740)

  • December 11, 2020

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Paris, France

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Quality Management
    • Transplant Accreditation

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Clinical Quality Improvement
    • Transplant Research

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Transplant Quality Management
    • Clinical Trials

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Quality Assurance
    • Oncology

  • #5

    AORN A. Cardarelli
    AORN A. Cardarelli

    Naples, Italy

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Quality Management Implementation

Original Source(s)

The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group Poster Session (P722-P740)

  • December 11, 2020

Related Content

Case Report and Epidemiological Investigation of Healthcare-associated Plasmodium falciparum Malaria Transmission in Westchester County, New York—2023

Erratum: Regionally limited or rare infections: prevention after hematopoietic cell transplantation

Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis